NJMS-UH Cancer Center
Minority- Based
Community
Clinical Oncology
Program
Minority-Based CCOP
• Increase the availability of state-of-the –art
cancer treatment and research to minority
individuals...
Cancer Services at
University Hospital
• Approximately 22,000 patient encounters were
recorded for FY2009
• 2007 – 1132 ne...
Patient Population
Year Total Males % Females
%
Black % Hispanic
%
White % Other %
2005 1135 563
(49.6)
572
(50.4)
351
(30...
Subject Recruitment
5
Efforts to Address Barriers
• Hiring bilingual staff
• IMPACT NJ to develop a patient/family
educational video
• Patient N...
7
Future Directions
• Hire staff
• Open treatment and cancer prevention
trials
• Website
• Develop additional recruitment st...
Team Members
• Medical Director
– Robert Wieder, MD, PhD
• Program Manager
– Tracie Saunders, RN, MS
• Research Coordinato...
Through Oncology
Research HOPE is
becoming a REALITY
Cancer Research Office
973-972-7789
Upcoming SlideShare
Loading in …5
×

"Minority- Based Community Clinical Oncology Program" (ppt)

595 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
595
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • The Community Clinical Oncology Program is a network for conducting cancer prevention and treatment clinical trials by community medical practitioners. The network connects academic centers with community physicians who accrue patients to those trials.
    MCCOP must meet the same criteria as a CCOP but also have 40% of their new cancer patients from minority populations. There are 50 CCOPS and 14 MB-CCOPS currently funded in 35 states. Recognizing that large populations of minority patients receive their medical care in academic hospitals – universities are eligible to apply for MB-CCOP.
  • Seen in a variety of settings including the DOC and outpatient clinics scattered throughout Ambulatory Care Services
    Diagnosed younger a
  • To demonstrate the diverse distribution of the patient population at UH I have presented a grid of the race and ethnic distribution of new patients with cancer in the last three years. The number of minorities is roughly the same demonstrating stable local populations. May speak a language other than English, including Spanish, Portuguese and Creole.
    Approximately 69% of the patients served by the Cancer program are in the Nwk metropolitian area. 75% of patients in our catchment atead are covered by Medicaid, Medicare of CC. This number has been increasing due to budgetary cuts in CC from the State of NJ and recent moves from funnel non-paying patients.
  • Efforts to address barriers to enrollment have included hiring bilingual staff from the community who knows how to talk to a patient about the studies and build a trustful relationship with the patient. In addition, the office collaborated with IMPACT NJ to develop a patient/family educational video outlining the clinical trials experience as told by patients from the community enrolled at University Hospital. This video is used to educate patients about clinical trials prior to being offered their treatment options. However, the most successful program implemented to date has been the development of the Patient Navigator Program.
  • Navigator program initiated for Breast Cancer patients. Arrows indicate involvement of the navigator in all aspects of patient flow, including coordination of clinic appointments in Radiation, Medical, and Surgical Oncology. The navigator is subsequently involved in all aspects of the patient’s care.
    In 2005, the navigator concept was successfully introduced by the Research Office to address identified barriers to screening and enrollment to protocols for locally advanced head and neck cancer. Using this model, a grant was submitted to and awarded by the Avon foundation to hire and retain a Breast Patient Navigator. The core research responsibilities of the navigator are the following:
    Has a working knowledge of the protocols
    Evaluates each patient for potential participation in an available clinical trial at the Cancer Center
    Identifies potential candidates for protocol in Breast clinic prior to the patient being seen by either Radiation Oncology or Medical Oncology
    Provides the patient ahead of time with an informed consent and describes in lay terms the study. When the patient sees Radiation Oncology or Medical Oncology, protocol therapy can be incorporated into the initial discussion.
     
    Enrollment to breast cancer clinical trials has significantly increased in the last 2 years. The navigator has navigated 217 women, screened 49 potential eligible and enrolled 22 (45% of screened). Many of the women screened signed consent but were not eligible due to secondary medical conditions. Due to the overwhelming success of the navigator program, the Susan G. Komen foundation has agreed to extend funding for an additional year.
  • "Minority- Based Community Clinical Oncology Program" (ppt)

    1. 1. NJMS-UH Cancer Center Minority- Based Community Clinical Oncology Program
    2. 2. Minority-Based CCOP • Increase the availability of state-of-the –art cancer treatment and research to minority individuals within their own community • Proven track record for enrollment to NCI- sponsored studies • Joint efforts of several departments within the NJ Medical School 2
    3. 3. Cancer Services at University Hospital • Approximately 22,000 patient encounters were recorded for FY2009 • 2007 – 1132 newly diagnosed patients – Younger and more advanced stage of disease • 40% AJCC stage III/IV compared to 27% nationwide • Unusually high number of sarcoma, cervical, hepatic and head/neck carcinomas 3
    4. 4. Patient Population Year Total Males % Females % Black % Hispanic % White % Other % 2005 1135 563 (49.6) 572 (50.4) 351 (30.9) 265 (23.3) 429 (37.9) 90 (7.9) 2006 1252 658 (52.6) 594 (47.4) 392 (31.3) 307 (24.5) 307 (24.5) 76 (6.1) 2007 1132 589 (52.1) 541 (47.9) 394 (34.8) 261 (23.1) 359 (31.7) 118 (10.4) 4
    5. 5. Subject Recruitment 5
    6. 6. Efforts to Address Barriers • Hiring bilingual staff • IMPACT NJ to develop a patient/family educational video • Patient Navigator Program 6
    7. 7. 7
    8. 8. Future Directions • Hire staff • Open treatment and cancer prevention trials • Website • Develop additional recruitment strategies • Partner with community organizations 8
    9. 9. Team Members • Medical Director – Robert Wieder, MD, PhD • Program Manager – Tracie Saunders, RN, MS • Research Coordinator – Yasmeen Barber, BA • Regulatory Coordinator – Karen Jackson, CIP • Data Manager • Research Nurse • Program Assistant 9
    10. 10. Through Oncology Research HOPE is becoming a REALITY Cancer Research Office 973-972-7789

    ×